BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  HSS to Honor Paul M. Pellicci, MD, Chief Emeritus of the Hip Service, and Senator William W. Bradley at Tribute Dinner on June 4

  Hospital for Special Surgery (HSS) will present Paul Pellicci, MD, Chief Emeritus of the Hip Service, with the Lifetime Achievement Award at the Hospital’s 35th Tribute Dinner.

  May 30, 2018

   · 

  4 min read
• Job Trends

  National Philanthropy Day in Colorado Accepting Nominations

  National Philanthropy Day in Colorado is accepting nominations for outstanding philanthropic individuals, businesses, organizations and foundations.

  May 30, 2018

   · 

  1 min read
• Pharm Country

  Lycera to Present on First-in-class RORgamma Agonist Candidate LYC-55716 at the 2018 ASCO Annual Meeting

  Lycera Corp. announced presentations of the company’s novel immuno-oncology therapeutic candidate, LYC-55716, to take place during the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

  May 30, 2018

   · 

  5 min read
• Job Trends

  Pivot Health Expands Its State Availability Footprint as Trump Administration Readies to Release New Rules on Short Term Health Plans

  Pivot Health announced it is releasing its short term medical (STM) insurance products in seven additional states.

  May 30, 2018

   · 

  3 min read
• Biotech Bay

  Geom Therapeutics To Present Data From Antibiotic Drug Development Programs At ASM Microbe

  Geom Therapeutics, Inc. announced upcoming data presentations at the American Society of Microbiologists (ASM) Microbe 2018 Annual Meeting.

  May 30, 2018

   · 

  6 min read
• Drug Development

  CellMax Life Launches Zenith, a U.S. Clinical Study for the Advancement of Blood Tests for Early Cancer Detection, With the Goal of Seeking FDA Approval

  Study expected to improve upon ASCO GI results that showed 84 to 88 percent accuracy at a sub-$200 price point for the test

  May 30, 2018

   · 

  4 min read
• Policy

  Artelo Biosciences Commences Trading On OTCQB

  Artelo Biosciences, Inc. is pleased to announce that as of May 21, 2018, its shares began trading on the OTCQB under the symbol ARTL.

  May 30, 2018

   · 

  3 min read
• Policy

  BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement

  BIOLASE, Inc. announced that it has received a letter from Nasdaq Listing Qualifications confirming that the Company has regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market.

  May 30, 2018

   · 

  4 min read
• FDA

  Legend Announces FDA clearance of IND application on CAR-T immuno-cell therapy for the Treatment of Multiple Myeloma

  LCAR-B38M CAR-T therapy (JNJ-68284528) to be developed as part of strategic partnership between Legend and Janssen

  May 30, 2018

   · 

  4 min read
• Biotech Bay

  Eiger BioPharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference

  Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will present a corporate update at Jefferies 2018 Global Healthcare Conference.

  May 30, 2018

   · 

  1 min read